PubRank

M C Paik

Author PubWeight™ 49.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998 5.54
2 Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke 2001 4.07
3 High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001 2.85
4 Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 1998 2.70
5 The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999 2.68
6 Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008 2.09
7 Physical activity and risk of ischemic stroke in the Northern Manhattan Study. Neurology 2009 2.02
8 Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke 1997 2.00
9 Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study. Stroke 2001 1.58
10 Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001 1.43
11 Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial. Stroke 2000 1.34
12 Predictors of resource use after acute hospitalization: the Northern Manhattan Stroke Study. Neurology 2000 1.31
13 Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology 1999 1.29
14 Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997 1.27
15 Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. Neurology 2011 1.22
16 Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000 1.19
17 Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology 2004 1.11
18 Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke 1998 1.11
19 Generalized estimating equation model for binary outcomes with missing covariates. Biometrics 1997 1.08
20 Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology 2005 1.07
21 High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology 2009 1.05
22 Quality of life declines after first ischemic stroke. The Northern Manhattan Study. Neurology 2010 1.04
23 Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998 1.03
24 Treatment for the secondary prevention of stroke in older patients: the influence of dementia status. J Am Geriatr Soc 1999 1.00
25 Gender differences in self-report of recovery after stroke: the Northern Manhattan Study. Neurology 2006 0.97
26 The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke. Int J Stroke 2010 0.90
27 Multiple imputation methods for the missing covariates in generalized estimating equation. Biometrics 1997 0.88
28 Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997 0.86
29 Matched case-control data analysis with selection bias. Biometrics 2001 0.84
30 Misclassification of dementia subtype using the Hachinski Ischemic Score: results of a meta-analysis of patients with pathologically verified dementias. Ann N Y Acad Sci 1997 0.83
31 Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 1996 0.83
32 Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke. Ann N Y Acad Sci 1997 0.80
33 Assessment of cognition in advanced AD: the test for severe impairment. Neurology 1999 0.76
34 Using missing data techniques to explore the lack of survival effect: illustration with the CABG patch trial. Stat Med 1999 0.75